YAP1 and lung carcinoma: Since ivermectin is a compound that targets yes-associated protein 1 (YAP1) [171], it is anticipated to exhibit anti-tumoral effects against ovarian, gastric, colorectal, and lung cancers, for which high expression of YAP1 is thought to be a prognostic indicator [172,173,174,175,176].